Key result
Subendocardial analysis of stress total perfusion deficit improves CAD detection over transmural analysis.
Why the study?
With 18F-flurpiridaz entering clinical use, researchers sought to assess whether subendocardial analysis for stress and ischemic total perfusion deficit could enhance coronary artery disease detection compared to transmural analysis and expert physician assessments.
Does automated subendocardial quantitative analysis of 18F-flurpiridaz PET improve the detection of coronary artery disease compared to transmural analysis or expert visual reading in patients with known or suspected CAD?
Observational (n=753)
Blinded readers
Yes
Does automated subendocardial quantitative analysis of 18F-flurpiridaz PET improve the detection of coronary artery disease compared to transmural analysis or expert visual reading in patients with known or suspected CAD?
Absolute Event Rate: 0.795% vs 0.762%
p-value: p=0.013
Automated subendocardial quantitative analysis of 18F-flurpiridaz PET significantly improves the detection of moderate coronary artery disease compared to standard transmural analysis and expert visual assessment.
May support subendocardial PET analysis for CAD detection; hypothesis-generating and requires prospective validation.
PURPOSE: F-flurpiridaz, is set to enter clinical use soon following its recent regulatory approval. We developed an approach for evaluating subendocardial analysis for stress total perfusion deficit (TPD) and ischemic TPD, assessed its performance for detection of coronary artery disease (CAD) and compared these measures to transmural analysis and expert physician assessments. METHODS: F-flurpiridaz phase III clinical trial (NCT01347710) were used. The subendocardial layer was automatically defined on the left ventricular contours and used for the derivation of polar maps. Areas under the receiver operating characteristic curve (AUC) for quantitative and visual measures were evaluated for detecting CAD, defined as ≥ 50% stenosis by invasive coronary angiography. RESULTS: In total, 753 cases were analyzed, with a median age of 63 (interquartile range 56,69) and 69% male. AUC for detecting ≥ 50% stenosis was higher for subendocardial than transmural analysis for stress (0.795 vs. 0.762, respectively; p = 0.013) and ischemic (0.795 vs. 0.767, respectively; p = 0.049) TPD. Subendocardial and transmural TPD achieved diagnostic performance greater than or comparable to that of the readers' assessments in the total population as well as across subgroups of interest. CONCLUSION: Subendocardial analysis of ischemic perfusion improves the detection of CAD compared to transmural quantitative analysis or expert visual reading. These measures can be derived automatically with minimal user interaction. Integrating TPD quantitative measures could standardize the diagnostic approach for this novel tracer.
No takes yet. Share an insight, caveat, or question.
Builoff et al. (2025) conducted an observational in Coronary artery disease (n=753). Subendocardial quantitative analysis of 18F-flurpiridaz PET vs. Transmural quantitative analysis was evaluated on Detection of CAD (≥50% stenosis) measured by Area Under the Curve (AUC) for stress total perfusion deficit (p=0.013). Subendocardial analysis of stress total perfusion deficit improved the detection of coronary artery disease compared to transmural analysis (AUC 0.795 vs. 0.762, p=0.013).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: